Virtu Financial LLC Imv Inc. Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 17, 2022	SELL	$1.07 - $1.5 $67,783 - $95,023	-63,349 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$1.22 - $1.78 $77,285 - $112,761	63,349 New	63,349 $77,000
Q3 2021 Nov 12, 2021	SELL	$1.35 - $2.16 $27,815 - $44,504	-20,604 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$2.12 - $3.24 $43,680 - $66,756	20,604 New	20,604 $45,000
Q1 2021 May 19, 2021	SELL	$2.92 - $4.41 $180,461 - $272,546	-61,802 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$2.9 - $4.4 $179,225 - $271,928	61,802 New	61,802 $190,000

Ticker IMV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,452,200
Description
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is P...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.